Agoracom Blog Home

Archive for the ‘All Recent Posts’ Category

Red Light Holland $TRIP.ca $TRUFF Engages Former Canadian Special Operations Forces Officer, Glenn Cowan, Founder of One 9 Investments, to Advisory Board $RVV.ca $PSYC $FTRP $BUZZ

Posted by AGORACOM at 10:50 AM on Friday, March 5th, 2021
https://i.ibb.co/ZdKv64V/Red-Light-Holland-Square.jpg

Red Light Holland Corp. (CSE: TRIP) (“Red Light Holland” or the “Company“), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has engaged Glenn Cowan, a Veteran of the Canadian Special Operations Forces Command (CANSOFCOM,) to the Red Light Holland Advisory Board joining Chair, Bruce Linton, and a team of talented and experienced Advisors. Cowan is also the founder of One 9 Investments Inc. which he started in 2013 while serving as a Squadron Commander in the Armed Forces. Having operated on multiple combat deployments in Afghanistan, sensitive information operations in the Middle East, and Hostage Recovery operations in Africa, Cowan brings his strategic planning and tactical command experience coupled with his progressive stance for supporting Veterans plus his investment expertise to the Red Light Holland team.

“Having served in Special Operations Forces for most of my adult life, I’m intimately aware of the physical and psychological stressors that our service men and women face on a daily basis and in retirement. When mission planning we prided ourselves on ‘out of the box’ thinking, and it’s time we apply this same creative through process to the manner in which we support our Veterans and society as a whole especially given the increase attention to mental health awareness,” said Cowan, Founder of One 9 Investments Inc. “I was introduced to the, in my opinion, positive benefits of psychedelics and microdosing during my own journey of adapting to life after the military and now as a tech investor in venture capital, I’ve come to appreciate some of the best technological innovation is naturally occurring.”

“Adding Glenn Cowan to the Red Light Holland Advisory Board is an honour for the Company. I have the utmost respect for our Armed Forces, past and present, and we appreciate Glenn’s transparency and mission in supporting those who have served through his personal investments into their well-being and through his financial investments into companies who produce military technology. We look forward to his expertise and his empathetic and huge heart to continue to help support our Military men and women and our Veterans on all levels,” said Todd Shapiro, the Chief Executive Officer and Director of Red Light Holland.

Read More: https://agoracom.com/ir/RedLightHolland/forums/discussion/topics/756659-red-light-holland-engages-former-canadian-special-operations-forces-officer-glenn-cowan-founder-of-one-9-investments-to-advisory-board/messages/2306675#message

Loncor $LN.ca $LONCF Announces Additional Results from Infill Drilling within Open Pit Shell at its Adumbi Deposit $ABX $NGT $GOLD $TECK

Posted by AGORACOM at 10:17 AM on Thursday, March 4th, 2021
This image has an empty alt attribute; its file name is Loncor-Small-Square.png
  • Borehole LADD008 intersects 43.10 metres grading 1.68 g/t Au, 0.78 metres grading 21.8 g/t Au and 14.98 metres grading 3.62 g/t Au, including 3.09 metres grading 13.28 g/t Au

Loncor Resources Inc. (“Loncor” or the “Company“) (TSX: “LN”; OTCQX: “LONCF”; FSE: “LO51”) is pleased to announce further significant assay results from its drilling program within its 84.68% owned Imbo Project in the eastern part of the Ngayu greenstone belt in the Democratic Republic of the Congo. The final infill core hole within the Adumbi open pit shell, LADD008 intersected 43.10 metres grading 1.68 g/t gold, 0.78 metres grading 21.8 g/t gold and 14.98 metres grading 3.62 g/t gold including 3.09 metres grading 13.28 g/t gold.

Mineralized sections for borehole LADD008 are summarised in the table below:

Borehole
Number
From (m)To (m)Intersected
Width (m)
Grade (g/t) Au
LADD008235.05278.1543.101.68
LADD008291.80298.907.101.34
LADD008305.15305.930.7821.8
LADD008323.80338.7814.983.62
LADD008
including
335.75338.783.0913.28


Borehole LADD008 intersected the mineralization at a vertical depth of 272 metres below surface and within the southeastern boundary of the US$1,500 open pit shell (see Figures 2 and 3 below), and had an inclination of minus 65 degrees and azimuth of 218 degrees at the start of hole and regular measurements of inclination and azimuth were taken at 30 metre intervals down the hole. All core was orientated, and it is estimated that the true widths of the mineralised sections are 62% of the intersected width. All intercepted grades are uncut.

Drilling is now focussed on the downdip/down plunge extensions below the open pit shell where the gold mineralization remains open. The deepest core hole of this drilling campaign, LADD009 has now been completed and assays are awaited. Boreholes LADD011 and LADD012 are currently being drilled (LADD010 was abandoned before reaching target depth due to mechanical problems and LADD012 is being drilled in its place).

Commenting on these latest drilling results, Loncor President Peter Cowley said: “We continue to be impressed with the drill results at Adumbi. All four completed infill holes within the open pit shell have intersected significant gold mineralization with an improvement in grade and thickness compared to the previous block model, and further studies will now be undertaken to quantify this increase in terms of mineral resources within the open pit shell.”

The objective of the current drilling program at Adumbi is to outline additional mineral resources to the current inferred mineral resource of 2.5 million ounces of gold on Loncor’s 84.68%-owned Imbo Project which contains the Adumbi, Kitenge and Manzako deposits (inferred mineral resources of 30.65 million tonnes grading 2.54 g/t Au).

Read More: https://agoracom.com/ir/LoncorResources/forums/discussion/topics/756580-loncor-announces-additional-results-from-infill-drilling-within-open-pit-shell-at-its-adumbi-deposit/messages/2306504#message

Loop Insights $MTRX $RACMF Appoints Former Epson General Manager of Global Brand & Marketing Communications, Ian Cameron, as VP of Marketing to Support Loop’s Continued Global Expansion in 2021 $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 9:45 AM on Thursday, March 4th, 2021
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png
  • Announced the appointment Ian Cameron, former General Manager of Global Brand & Marketing Communications at Seiko Epson Corporation, as its VP of Marketing, effective March 15th, 2021
  • Ian Cameron is a global marketing, eCommerce, and brand executive with over 20 years of experience delivering positive business results for major companies, including Epson, a global printing equipment leader with a market cap of $US 5.73 billion

VANCOUVER, British Columbia, March 04, 2021 – Loop Insights Inc. (MTRX:TSXV RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue tracing for the brick and mortar space, is pleased to announce the Company has appointed Ian Cameron, former General Manager of Global Brand & Marketing Communications at Seiko Epson Corporation, as its VP of Marketing, effective March 15th, 2021.

Cameron Joins Loop Insights After Establishing and Managing Epson’s Global Marketing Team

Ian Cameron is a global marketing, eCommerce, and brand executive with over 20 years of experience delivering positive business results for major companies, including Epson, a global printing equipment leader with a market cap of $US 5.73 billion.

Epson (an abbreviation for “Son of Electronic Printer”), is a Japanese electronics company and one of the world’s largest manufacturers of computer printers, and information and imaging-related equipment.

Loop Insights CEO Rob Anson stated: “Ian’s experience working with a global leader such as Epson speaks to the level of talent that Loop has been able to attract. As a global marketing and communications expert, Ian is another key strategic addition to our team. I look forward to working alongside Ian and witnessing his impact on our marketing efforts as Loop continues to position and prove itself as a global leader in the Artificial Intelligence and data applications space.”

Strong Executive Leadership Positions Loop to Continue to Accelerate Expansion for 2021

Under Cameron’s leadership, Epson centralized redundant regional activities increasing profitability significantly and improved their global digital user experience while saving millions of dollars annually for the company through a Global digital transformation project that unified multiple disparate regional content management, eCommerce, and product information systems.

Cameron’s experience in driving successful enterprise global marketing campaigns is expected to significantly contribute to continued growth and scale for Loop Insights in 2021.

Ian Cameron stated: “I am very excited to join the Loop team and to support and contribute to the growth of the company. Loop’s clear multifaceted value propositions are very exciting and as a marketing professional, the value of attribution, campaign performance, and the granularity of the data analytics that Loop is able to provide is simply unparalleled. Loop’s technology is something that marketers only wish for and dream of.”

On January 28th , Loop Insights appointed Tamer Shafik, the former Director of Solution Architecture at NTT Data Corp of Japan, as the company’s new Chief Technology Officer in support of Loop’s global scale. Shafik joined the company as a result of a flourishing partnership between Loop and NTT Data. Shafik’s immense experience and skillset have already made a significant impact with the Loop team, transforming the product department in a short amount of time.

Read More: https://agoracom.com/ir/LoopInsights/forums/discussion/topics/756557-loop-insights-appoints-former-epson-general-manager-of-global-brand-marketing-communications/messages/2306457#message

Peak $PKK.ca $PKKFF Provides Updates on Implementation of Fund Transfer Services and Cash Position from Exercise of Warrants $MOS.ca $MOGO.ca CTZ.ca $TRAD.ca

Posted by AGORACOM-JC at 9:26 AM on Thursday, March 4th, 2021
Peak Fintech Group (@PEAK_Fintech) | Twitter
  • Reached an important step in the implementation of payment processing and fund transfer services on its Cubeler Lending Hub platform.
  • Peak remains on track to launch the payment processing and fund transfer services on Lending Hub in the second quarter of 2021.
  • Through the first two months of 2021, Peak received a total of $2,665,577 in cash as a result of the exercise of warrants, including a combined $500,000 from Peak’s CEO, CFO and China CEO

Montreal, Quebec–(March 4, 2021) –  Peak Fintech Group Inc. (CSE: PKK) (OTCQX: PKKFF) (“Peak” or the “Company”), an innovative Fintech service provider to the Chinese commercial lending sector, today announced that it has reached an important step in the implementation of payment processing and fund transfer services on its Cubeler Lending Hub platform.

Peak announced earlier this year that it had signed an agreement with China UnionPay subsidiary, Rongbang Technology Ltd. (“Rongbang”) that will allow it to process payments, settle transactions and transfer funds between lending institutions, banks and the businesses that are part of its Lending Hub ecosystem. After holding several working sessions with Rongbang’s service implementation team, the Company has now completed the setup of the test environment where virtual replications of both the Lending Hub platform and the China UnionPay network will co-exist from this point forward. Setting up the test environment was identified as one of the key milestones for the Company leading up to the launch of services. Peak is now in position to simulate transactions, test and study the results, and, if need be, make the necessary adjustments in its development environment, all of which will lead to a better understanding of the UnionPay network prior to the services going live. Peak remains on track to launch the payment processing and fund transfer services on Lending Hub in the second quarter of 2021.

Cash Position Resulting from Exercise of Warrants:

Peak’s market performance over the past few months has placed virtually all of the Company’s issued and outstanding convertible securities “in the money”. That has triggered a regular and consistent exercise of Peak warrants since about the half-way point of the fourth quarter of 2020, and continued in 2021. Through the first two months of 2021, Peak received a total of $2,665,577 in cash as a result of the exercise of warrants, including a combined $500,000 from Peak’s CEO, CFO and China CEO. This puts the Company’s cash balance at more than $7.8M as of February 28, 2021.

Read More: https://agoracom.com/ir/PeakFintechGroup/forums/discussion/topics/756561-peak-provides-updates-on-implementation-of-fund-transfer-services-and-cash-position-from-exercise-of-warrants/messages/2306461#message

American Creek: $AMK $STNG Stinger Resources Inc. To Commence Trading On Friday March 5th, 2021 $TUD.ca $ESK.ca $SEA.ca

Posted by AGORACOM at 8:47 AM on Thursday, March 4th, 2021
American Creek Provides Update on Its First Quarter Filings

Stinger Resources Inc. (TSX-V: STNG) (the “Company” or “Stinger”) is pleased to announce that it has now received final approval from the TSX Venture Exchange and its common shares will commence trading on Friday, March 5, 2021, under the symbol “STNG”. 
 
Darren Blaney, Chief Executive Officer of Stinger stated the following: “We are very pleased to have successfully completed this Spinout transaction. We again thank all of the American Creek shareholders for their confidence and support over the years and we look forward to that support continuing to be rewarded as we anticipate the future success of American Creek as well as newly launched Stinger.”
 
About Stinger Resources Inc.:
 
Stinger holds interests in gold and silver properties in British Columbia, including the 100% owned past producing Dunwell Mine which is located near Stewart in the prolific “Golden Triangle”.
 
The Company also holds the D1 McBride project, also located in the “Golden Triangle”.
 
In addition, Stinger owns the Gold Hill project located near Fort Steele, as well as optioned interests in the Ample Goldmax, Silver Side and Glitter King properties, all of which are located in other prospective areas of the Province of British Columbia.
 

XPhyto Therapeutics $XPHY.ca $XPHYF Completes Corporate Rebranding and Launches New Website $NGM.ca $SONA.ca $HBP.ca $MIR.ca $IPA.ca

Posted by AGORACOM at 8:05 AM on Thursday, March 4th, 2021
http://blog.agoracom.com/wp-content/uploads/2021/01/XPHYTO-70-x-70.jpg
  • Rebranding Reflects XPhyto’s Commitment To Operational Achievement
  • Product Development Advance From The Lab To The Clinic
  • Cusp Of Two Major Commercial Milestones Related To Our Rapid Point-Of-Care COVID-19 PCR Test System
  • A Bioscience Accelerator At The Leading-Edge Of The Life Science Industry

XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”), is pleased to announce that the Company has completed a corporate rebranding and launched a new website which can be viewed at www.xphyto.com.

The rebranding decision reflects the Company’s commitment to operational achievement in 2021 as a number of product development programs advance from the laboratory to the clinic. As a bioscience accelerator at the leading-edge of the life science industry, XPhyto is targeting value creation through commercialization of its development pipeline and focused investment in impact driven innovation.

“The Company is excited to introduce a fresh look at such a pivotal point in our business growth,” said Hugh Rogers, CEO & Director of XPhyto. “With all technical requirements fulfilled, we are on the cusp of two major commercial milestones related to our rapid point-of-care COVID-19 PCR test system. With expected ISO certification and CE-IVD approval pending, we are excited to enter the next phase of our business with a positive, crisp and energetic new image.”

The Company will provide further information and updates in due course. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 pandemic. Further, its COVID-19 related test products are not yet approved and are still subject to risks associated with the regulatory approval process.

Read More: https://agoracom.com/ir/XphytoTherapeutics/forums/discussion/topics/756560-xphyto-completes-corporate-rebranding-and-launches-new-website/messages/2306460#message

VIDEO – Mountain Valley MD $MVMD $MVMDF FDA Application First Step Toward Human Applications For Game Changing Ivectosol™ $CTLT $MRNA $NVAX

Posted by AGORACOM-JC at 5:30 PM on Wednesday, March 3rd, 2021

Mountain Valley MD takes existing Vaccines & Drugs and delivers them better. Into the body better and by transportation. MVMD’s solubility technology applied to the Ivermectin drug is the only form in the world that are currently approved by the US Food and Drug Administration (FDA), making it a leading candidate for human injection and sublingual applications.

To this end they have created Ivectosol™ and it could be a massive disruption in the Vaccine Industry.

If you are looking to learn more about vaccine technologies. This video is a must watch with Dennis Hancock & Mike Farber of MVMD.

See how Mountain Valley MD is doing more with less. 

Red Light Holland $TRIP.ca $TRUFF Red Light Holland’s iMicro Digital Care App Launches Virtual Telecounseling $RVV.ca $PSYC $FTRP $BUZZ

Posted by AGORACOM at 10:03 AM on Wednesday, March 3rd, 2021
https://i.ibb.co/ZdKv64V/Red-Light-Holland-Square.jpg

Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company”) is pleased to announce the launch of its Virtual Telecounseling membership program on the Company’s iMicrodose Digital Care App in the Netherlands. The app currently in use by consumers, is accessible from phones, tablets or computers. The telecounseling membership program will be seamlessly integrated into the privacy first iMicro Digital Care web app creating a new frontier for virtual psychedelic platforms. Online support will be offered to adults exploring microdosing with iMicrodose packs powered by Red Light Holland in the Netherlands. Members will be able to approve and share their iMicro Digital Care app data and connect with Red Light Holland’s certified therapist and microdosing expert, Jeff Hamburg, who will provide live virtual telecounseling. Adults can now register to the membership program by going to www.iMicrodose.nl.

“Red Light Holland is extremely proud to introduce virtual telecounseling, the use of digital information and communication technologies to help support the microdosing community. This is just another example of how we are promoting responsible use of our iMicrodose packs. This membership program will bring expert knowledge to the people in the Netherlands,” said Red Light Holland CEO and Director, Todd Shapiro. “I’m excited to have an experienced counselor like Jeff Hamburg connect with Red Light Holland consumers via telecounseling facilitating growth and wellbeing.”

“It’s thrilling to work with Red Light Holland, a company that is immediately building support structures for their customers. I’m excited to be able to offer my experience and knowledge on their consumer’s microdosing journey virtually through telecounseling on the iMicro Digital Care app,” said therapist and microdosing expert Jeff Hamburg.

The company will be offering two tiers of 3 month memberships:

(i) Growth Membership, priced at 75 euro: Includes bi-monthly online support group sessions led by Jeff Hamburg, textual consultation through the iMicro app, a monthly microdosing and creativity event as well as discounts and unique benefits for purchasing Red Light Holland merchandise.

(ii) Transform Membership, currently priced at a rate of 225 euro: For those who are interested in more personal one on one counseling with Jeff Hamburg. The transform membership will include 5 hour private sessions along with all benefits of the Growth membership.

Jeff Hamburg will also be offering short consultations for adults in the Netherlands curious to learn more about microdosing. Adults can register to the membership program or book a free consultation by going to www.iMicrodose.nl.

Read More: https://agoracom.com/ir/RedLightHolland/forums/discussion/topics/756476-red-light-holland-s-imicro-digital-care-app-launches-virtual-telecounseling/messages/2306221#message

Royal Helium $RHC.ca Announces Production Testing Underway at Climax-1 and Climax-2 $DME.ca $APD $AHELF

Posted by AGORACOM at 9:58 AM on Wednesday, March 3rd, 2021

Royal Helium Ltd. (“Royal” or the “Company”) (TSXV: RHC) announces that it has engaged two service rigs and that the completions and testing program has been initiated at Climax-1 and Climax-2.  The finalized testing program, which was developed in concert with Sproul Associates Ltd., involves the sequential perforation and gas flow testing of several separate intervals identified during drilling.  Finalized results from the testing program will be reported as the information becomes available.

Royal further announces that the Climax-3 helium well has been drilled to its target depth of 2,600 metres.  Royal’s completion team is reviewing the log data at Climax-3 to determine the intervals to be production tested. The completion and testing program at Climax-3 will commence once testing is complete on Climax-2. 

Andrew Davidson, President and CEO of Royal comments, “We are pleased to have our initial 3 wells at Climax drilled to target depth and we are excited to be production testing these high value targets. We want to thank the team from Savanna 419 for their diligent work in completing this drilling program safely and effectively”. 

Mr. Davidson continues “With 2 service rigs operating we anticipate the testing to be completed on all 3 wells over the next few weeks. While any significant developments will be announced as they are received, all results will be evaluated by Sproule for a potential helium resource and production over multiple separate zones within this large structural closure”.

The three Climax wells were drilled into the Precambrian basement, directly below the Deadwood Formation. The Deadwood is a sand and shale sequence that is a known helium production zone in Saskatchewan. These first three wells are targeting different parts of the same large structural trap identified on the central portion of the Climax land block.

Read More: https://agoracom.com/ir/RoyalHelium/forums/discussion/topics/756474-royal-helium-announces-production-testing-underway-at-climax-1-and-climax-2/messages/2306214#message

Mountain Valley MD $MVMD $MVMDF Proceeding with FDA Pathway Application for Novel Ivectosol™ $CTLT $MRNA $NVAX

Posted by AGORACOM at 9:54 AM on Wednesday, March 3rd, 2021
This image has an empty alt attribute; its file name is MVMD-Small.png

Mountain Valley MD Holdings Inc. (the “Company” or “MVMD“) (CSE: MVMD) (FRA: 20MP) (OTCQB: MVMDF) is pleased to announce it has contracted Camargo Pharmaceutical Services, LLC (“Camargo”) to provide regulatory consulting services to support MVMD’s pursuit of U.S. Food and Drug Administration (FDA) approval of its novel Ivectosol™ rapid dissolve oral format.

Camargo is recognized as one of the most experienced global organizations who specialize in drug and combination device product development and approval utilizing the regulatory pathway provided for in Section 505(b)(2) of the US Federal Food, Drug, and Cosmetic Act.  Over the last decade, Camargo has established a leading track record with 505(b)(2) investigational new drug (“IND”) and new drug applications (“NDA” preparations and submissions, including participation in more than 1100 Agency meetings and more than 200 FDA NDA and ANDA (Abbreviated New Drug Applications) approvals.

“After successful pre-clinical studies of our novel solubilized Ivectosol™ sublingual in our pre-clinical trials, this is a critical next step in the approval process to support our human application objectives,” stated Mike Farber, Director of Life Sciences at Mountain Valley MD.   “Camargo will be a great partner to accelerate our efforts for the initial pre-IND presentation to the FDA outlining Ivermectin’s prior usage history and extensive safety record for the FDA’s assessment and approval pathway.”

The 505(b)(2) new drug application is one of three U.S. Food and Drug Administration drug approval pathways and represents an appealing regulatory strategy by way of helping to avoid unnecessary duplication of studies already performed on a previously approved drug.  The Company believes the 505(b)(2) pathway will result in a much less expensive and much faster route to approval, compared with a traditional development pathway, while creating a new, differentiated Ivermectin product with tremendous commercial value.

“Camargo is proud to partner with Mountain Valley MD to advance their novel solubilized Ivermectin sublingual wafer,” said Catherine Gatza, PhD, Vice President, Regulatory and Strategy at Camargo. “This program delivers important advantages to the parasitic infection treatment landscape by providing an alternative dosage form.”

As previously communicated, MVMD’s solubility technology applied to the Ivermectin drug is the only form in the world that uses strictly excipients that are currently approved by the US Food and Drug Administration (FDA), making it a leading candidate for human injection and sublingual applications as well as significantly broader husbandry and companion animal treatments based on its low viscosity.

“The U.S. FDA approval would prove the efficacy and safety of MVMD’s Ivectosol™ wafer at one of the highest standards in the world and would assist in facilitating greater access to key global markets in an accelerated capacity,” stated Dennis Hancock, President & CEO of Mountain Valley MD.  “The human approval pathway timed with our aggressive pursuit of husbandry applications, is core to making our Ivectosol™ products the number one commercial form of Ivermectin in the world.”

Read More: https://agoracom.com/ir/MountainValleyMD/forums/discussion/topics/756473-mountain-valley-md-proceeding-with-fda-505-b-2-pathway-application-for-novel-ivectosol/messages/2306213#message